BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns
Go back to BofA cuts ratings on four biopharma stocks over valuation and catalyst concerns| ALKERMES (NASDAQ: ALKS) | Delayed: 43.51 +0.12 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.39 | 52 Week High | $80.71 | |||
| Open | $44.27 | 52 Week Low | $27.14 | |||
| Day High | $44.79 | P/E | 334.69 | |||
| Day Low | $43.11 | EPS | $0.13 | |||
| Volume | 358,102 | |||||
| AMER PHYSICIANS (NASDAQ: AMPH) | Delayed: 23.80 +0.18 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.62 | 52 Week High | $21.53 | |||
| Open | $23.54 | 52 Week Low | $10.50 | |||
| Day High | $23.80 | P/E | 7.28 | |||
| Day Low | $23.45 | EPS | $3.27 | |||
| Volume | 11,343 | |||||
| (NYSE: BHVN) | Delayed: 13.74 +0.12 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.62 | 52 Week High | $ | |||
| Open | $13.90 | 52 Week Low | $ | |||
| Day High | $14.03 | P/E | N/A | |||
| Day Low | $13.56 | EPS | $ | |||
| Volume | 151,692 | |||||
